miradaprofesional.com. The US Drug Administration (FDA) has approved Amgen's first Enbrel biosimilar. This is Erelzi, a development of the Swiss company Sandoz, which is part of the Novartis group.
Industry news
miradaprofesional.com. The US Drug Administration (FDA) has approved Amgen's first Enbrel biosimilar. This is Erelzi, a development of the Swiss company Sandoz, which is part of the Novartis group.
recently published
Subscribe to receive a weekly summary of current events on biosimilar medicines in your email.